American Journal of Biomedical Research
ISSN (Print): 2328-3947 ISSN (Online): 2328-3955 Website: Editor-in-chief: Hari K. Koul
Open Access
Journal Browser
American Journal of Biomedical Research. 2021, 9(1), 5-9
DOI: 10.12691/ajbr-9-1-2
Open AccessReview Article

Ayurvedic Treatment of Bipolar Disorder

Ravi Kumar1, Chhater Singh2, , Sachin Tyagi1 and Nitish Kumar1

1Bharat Institute of Technology, Meerut (U.P.) India

2Dron College of Education, Sardhana Meerut (U.P.) India

Pub. Date: April 14, 2021

Cite this paper:
Ravi Kumar, Chhater Singh, Sachin Tyagi and Nitish Kumar. Ayurvedic Treatment of Bipolar Disorder. American Journal of Biomedical Research. 2021; 9(1):5-9. doi: 10.12691/ajbr-9-1-2


The bipolar disorder is a neurological dysfunction and it cause through many unwanted thought/ideas and unnecessary burden on brain. These alterations may cause intervantions in mood regulating circuits such as the limbic system, striatum system and prefrontal cortex. The exact pathophysiology of bipolar disorder is not known but some deficiencies in neurological system and brain are observed in BD patients. The three main types of bipolar disorder i.e. Bipolar I Disorder, Bipolar II Disorder, Cyclothymic disorder. The researchers are recommended some important medicinal herbs that reduce the symptoms of bipolar disorder like as Valerian, Passionflower, Ashawagandha etc. these all drugs are regulate the neurological system. After clinical trials of vitamin B complex and methylfolate on bipolar disorder patients, it proved these are useful in physical illness and it more effective with other herbal drugs. These drugs are regulating the level of Serotonin, Monoaminase and GABA.

bipolar disorder mania anxiety neurotransmitter depression

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Ayano G (2016). Bipolar Disorder: A Concise Overview of Etiology, Epidemiology Diagnosis and Management: Review of Literatures. SOJ Psychol, 3(1):1-8.
[2]  Goodwin FK, Jameson KR (2007). Manic-depressive illness: bipolar disorders and recurrent depression. Oxford University Press, Oxford, New York. Pp 231-237.
[3]  Charles L. Bowden (2008). Bipolar Pathophysiology and Development of Improved Treatments, 1235: 92-97.
[4]  Ressler KJ, Nemeroff CB (1999) Role of norepinefrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry. 46(9): 1219-33.
[5]  Brunello N, Tascedda F (2003). Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. Int J Neuropsychopharmacol. 6(2): 18190.
[6]  Kapczinski F, Freya BN, Zannattoa V (2004). Physiopathology of bipolar disorders: what has changed in the last 10 years? Rev Bras Psiquiatr. 26(Supl III):17-21.
[7]  Frey BN, Andreazza AC, Houenou J, Jamain S, Goldstein BI, Frye MA (2013). Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry. 47(4): 32132.
[8]  McCormick U, Murray B, McNew B (2015). Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses. JAA of Nurse Practitioners 27530- 542.
[9]  Brunello N, Tascedda F. Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. Int J Neuropsychopharmacol. 2003; 6(2):181-189.
[10]  Frey BN, Andreazza AC, Houenou J, Jamain S, Goldstein BI, Frye MA,. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry.
[11]  Axelson D, Goldstein B, Goldstein T, Monk K, Yu H, Hickey MB, Diagnostic Precursors to Bipolar Disorder in Offspring of Parents With Bipolar Disorder: A Longitudinal Study. Am J Psychiatry. 2015; 172(7): 638-646.
[12]  The Columbia Bipolar Genetic Study. Bipolar disorder and genetics. Available at Accessed: 2013, March 13.
[13]  Ayano G. Bipolar Disorder: A Concise Overview of Etiology, Epidemiology Diagnosis and Management: Review of Literatures. SOJ Psychol 2016:3(1), 1-8.
[14]  Ambelas A. Life events and mania: A special relationship. British Journal of Psychiatry. 1987; 150(2): 235-240.
[15]  Yapici Eser H, Kacar AS, Kilciksiz CM, Yalçinay-Inan M, Ongur D. Prevalence and associated features of anxiety disorder comorbidity in bipolar disorder: a meta-analysis and meta-regression study. Front Psychiatry 2018; 9: 229.
[16]  Onyeka IN, Collier Høegh M, Nåheim Eien EM, Nwaru BI, Melle I. Comorbidity of physical disorders among patients with severe mental illness with and without substance use disorders: a systematic review and meta-analysis. J Dual Diagn 2019; 15: 192-206.
[17]  McElroy SL, Winham SJ, Cuellar-Barboza AB,. Bipolar disorder with binge eating behavior: a genome-wide association study implicates PRR5-ARHGAP8. Transl Psychiatry 2018; 8: 40.
[18]  McIntyre RS, Correll C. Predicting and preventing bipolar disorder: the need to fundamentally advance the strategic approach. Bipolar Disord 2014; 16: 451-54.
[19]  Coello K, Kjærstad HL, Stanislaus S. Thirty-year cardiovascular risk score in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives. Aust N Z J Psychiatry 2019; 53: 651-62.
[20]  Goldstein BI, Carnethon MR, Matthews KA,. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2015; 132: 965-86.
[21]  Petri E, Bacci O, Barbuti M,. Obesity in patients with major depression is related to bipolarity and mixed features: evidence from the BRIDGE-II-Mix study. Bipolar Disord 2017; 19: 458-64.
[22]  Bora E, Yucel M, Fornito A, Berk M, Pantelis C. Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers? Acta Psychiatr Scand 2008; 118: 172-87.
[23]  Johansson V, Kuja-Halkola R, Cannon TD, Hultman CM, Hedman AM. A population-based heritability estimate of bipolar disorder—in a Swedish twin sample. Psychiatry Res 2019; 278: 180-87.
[24]  Fabbri C. The role of genetics in bipolar disorder. Curr Top Behav Neurosci 2020; published online August 7.
[25]  Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience 2009; 164: 331-43.
[26]  Stahl EA, Breen G, Forstner AJ,. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet 2019; 51: 793-803.
[27]  Chen DT, Jiang X, Akula N. Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry 2013; 18: 195-205.
[28]  Smeland OB,. Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence. Mol Psychiatry 2020; 25: 844-53.
[29]  Wang M, Zhang L, Gage FH. Modeling neuropsychiatric disorders using human induced pluripotent stem cells. Protein Cell 2020; 11: 45-59.
[30]  Andreazza AC, Duong A, Young LT. Bipolar disorder as a mitochondrial disease. Biol Psychiatry 2018; 83: 720-21.
[31]  Berk M, Kapczinski F, Andreazza AC,. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-17.
[32]  Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res 2014; 218: 61-68.
[33]  Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 2009; 70: 1078-90.
[34]  Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 2014; 53: 23-34.
[35]  Dargél AA, Godin O, Kapczinski F, Kupfer DJ, Leboyer M. C-reactive protein alterations in bipolar disorder: a meta-analysis. J Clin Psychiatry 2015; 76: 142-150.
[36]  Kieseppä T., Partonen T., Haukka J., Kaprio J., Lönnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry 2004.161(10), 1814-1821.
[37]  Kim YK, Hwang JA, Lee HJ, Yoon HK, Ko YH, Lee BH,. Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder. J Affect Disord 2014, 158, 127-132.
[38]  Kurita M, Nishino S, Numata Y, Okubo Y, Sato T. The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study. PLoS One 2014, 9(6), e100634.
[39]  Iasevoli F, Valchera A, Di Giovambattista E, Marconi M, Rapagnani MP, De Berardi D, Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. J Affect Disord 2013. 151(2), 540-550.
[40]  Ikeda M, Takahashi A, Kamatani Y, Okahisa Y, Kunugi H, Mori N,. A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder. Mol Psychiatry 2018, 23(3), 639-647.
[41]  Leszczynska-Rodziewicz A, Czerski PM, Kapelski P, Godlewski S, Dmitrzak-Weglarz M, Rybakowski J. A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: lack of association. Neuropsychobiology 2002, 45(4), 182-185.
[42]  Zill P., Engel R., Baghai TC, Juckel G., Frodl T., Müller-Siecheneder F (2002). Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology : 26(4), 489-493.
[43]  Pilkington K, Kirkwood G, Rampes H, Richardson J (2005). Yoga for depression: the research evidence. J Affect Disord. 89: 13-24.
[44]  Wood C (1993) Mood change and perceptions of vitality: a comparison of the effects of relaxation, visualization and yoga. J R Soc Med. 86:254-258.
[45]  Kjærgaard M, Waterloo K, Wang CE, (2012). Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry. 201:360-368.
[46]  Pan NL, Jiang MJ, Poon PWF, Huang AM (2006). The role of brain-derived neurotrophic factor in the antidepressant effects of Sudarshan Kriya Yoga. Master’s thesis.